ISL
LLY icon

Ingalls & Snyder LLC’s Eli Lilly LLY Stock Holding History

Ingalls & Snyder LLC’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.3M Buy
11,055
+203
+2% +$207K 0.36% 55
2026
Q1 		$9.98M Buy
10,852
+347
+3% +$352K 0.35% 58
2025
Q4 		$11.3M Sell
10,505
-697
-6% -$666K 0.41% 53
2025
Q3 		$8.55M Buy
11,202
+4,158
+59% +$3.09M 0.28% 67
2025
Q2 		$5.49M Buy
7,044
+124
+2% +$96.4K 0.19% 83
2025
Q1 		$5.71M Buy
6,920
+48
+0.7% +$39.9K 0.19% 78
2024
Q4 		$5.3M Sell
6,872
-130
-2% -$108K 0.21% 80
2024
Q3 		$6.2M Sell
7,002
-320
-4% -$288K 0.24% 74
2024
Q2 		$6.63M Sell
7,322
-203
-3% -$162K 0.29% 63
2024
Q1 		$5.85M Sell
7,525
-851
-10% -$606K 0.26% 70
2023
Q4 		$4.88M Sell
8,376
-1,255
-13% -$733K 0.22% 77
2023
Q3 		$5.17M Buy
9,631
+1,280
+15% +$660K 0.25% 72
2023
Q2 		$3.92M Sell
8,351
-3,303
-28% -$1.39M 0.19% 85
2023
Q1 		$4M Sell
11,654
-76
-0.6% -$25.6K 0.21% 80
2022
Q4 		$4.29M Sell
11,730
-50
-0.4% -$17.7K 0.23% 74
2022
Q3 		$3.81M Sell
11,780
-126
-1% -$39.9K 0.21% 80
2022
Q2 		$3.86M Buy
11,906
+115
+1% +$34.5K 0.2% 84
2022
Q1 		$3.38M Sell
11,791
-2,928
-20% -$754K 0.15% 112
2021
Q4 		$4.07M Sell
14,719
-455
-3% -$115K 0.18% 102
2021
Q3 		$3.51M Sell
15,174
-225
-1% -$55.5K 0.16% 120
2021
Q2 		$3.53M Sell
15,399
-125
-0.8% -$25.1K 0.16% 114
2021
Q1 		$2.9M Sell
15,524
-613
-4% -$120K 0.14% 124
2020
Q4 		$2.73M Buy
16,137
+414
+3% +$61.8K 0.13% 125
2020
Q3 		$2.33M Buy
15,723
+45
+0.3% +$6.96K 0.16% 113
2020
Q2 		$2.57M Sell
15,678
-485
-3% -$74.4K 0.15% 111
2020
Q1 		$2.24M Sell
16,163
-1,064
-6% -$146K 0.15% 115
2019
Q4 		$2.26M Buy
17,227
+1,275
+8% +$148K 0.12% 128
2019
Q3 		$1.78M Hold
15,952
– – 0.09% 164
2019
Q2 		$1.77M Buy
15,952
+850
+6% +$100K 0.09% 169
2019
Q1 		$1.96M Sell
15,102
-50
-0.3% -$6.08K 0.09% 158
2018
Q4 		$1.75M Sell
15,152
-3,250
-18% -$363K 0.09% 162
2018
Q3 		$1.98M Hold
18,402
– – 0.08% 167
2018
Q2 		$1.57M Hold
18,402
– – 0.07% 170
2018
Q1 		$1.42M Sell
18,402
-290
-2% -$23.3K 0.07% 175
2017
Q4 		$1.58M Buy
18,692
+70
+0.4% +$5.96K 0.07% 174
2017
Q3 		$1.59M Sell
18,622
-20
-0.1% -$1.64K 0.08% 158
2017
Q2 		$1.53M Buy
18,642
+190
+1% +$15.5K 0.08% 157
2017
Q1 		$1.55M Buy
18,452
+480
+3% +$38.4K 0.08% 166
2016
Q4 		$1.32M Buy
17,972
+940
+6% +$70K 0.07% 170
2016
Q3 		$1.37M Buy
17,032
+1,475
+9% +$118K 0.08% 167
2016
Q2 		$1.23M Sell
15,557
-15
-0.1% -$1.13K 0.07% 177
2016
Q1 		$1.12M Sell
15,572
-829
-5% -$62.7K 0.07% 165
2015
Q4 		$1.38M Sell
16,401
-100
-0.6% -$8.3K 0.09% 143
2015
Q3 		$1.38M Sell
16,501
-400
-2% -$33.8K 0.09% 142
2015
Q2 		$1.41M Buy
16,901
+89
+0.5% +$6.78K 0.08% 151
2015
Q1 		$1.22M Sell
16,812
-975
-5% -$69.4K 0.07% 160
2014
Q4 		$1.23M Buy
17,787
+159
+0.9% +$10.7K 0.07% 159
2014
Q3 		$1.14M Sell
17,628
-540
-3% -$34.2K 0.06% 169
2014
Q2 		$1.13M Sell
18,168
-1,925
-10% -$115K 0.06% 173
2014
Q1 		$1.18M Sell
20,093
-71
-0.4% -$3.96K 0.06% 167
2013
Q4 		$1.03M Sell
20,164
-4,749
-19% -$238K 0.06% 174
2013
Q3 		$1.25M Sell
24,913
-50
-0.2% -$2.62K 0.07% 155
2013
Q2 		$1.23M Buy
+24,963
New +$1.36M 0.08% 160

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ingalls & Snyder LLC's LLY Position: Q2 2026 in Review

Ingalls & Snyder LLC increased its Eli Lilly (LLY) stake by 1.9% in Q2 2026, buying an estimated $207K and bringing the position to 11,055 shares worth $13.3M. The position accounts for 0.36% of the portfolio, ranked #55.

Ingalls & Snyder LLC first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Ingalls & Snyder LLC held 11,055 shares of Eli Lilly worth $13.3M as of Q2 2026.
  • Ingalls & Snyder LLC bought 203 Eli Lilly shares in Q2 2026, an estimated $207K.
  • Eli Lilly made up 0.36% of Ingalls & Snyder LLC's portfolio in Q2 2026, its #55 holding.
  • Ingalls & Snyder LLC first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ingalls & Snyder LLC's 13F filing for Q2 2026, filed 14 Aug 2026.